| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |